Kloster Grafschaft, Pulmonary Medicine I, Home Mechanical Ventilation Unit and Sleep Laboratory, Schmallenberg, Germany.
Sleep. 2013 Aug 1;36(8):1163-71. doi: 10.5665/sleep.2878.
To compare the treatment effect of noninvasive positive pressure ventilation (NPPV) and anticyclic servoventilation in patients with continuous positive airway pressure (CPAP)-induced central sleep apnea (complex sleep apnea).
Randomized controlled trial.
Sleep center.
Thirty patients who developed complex sleep apnea syndrome (CompSAS) during CPAP treatment.
NPPV or servoventilation.
Patients were randomized to NPPV or servo-ventilation. Full polysomnography (PSG) was performed after 6 weeks. On CPAP prior to randomization, patients in the NPPV and servoventilator arm had comparable apnea-hypopnea indices (AHI, 28.6 ± 6.5 versus 27.7 ± 9.7 events/h (mean ± standard deviation [SD])), apnea indices (AI,19 ± 5.6 versus 21.1 ± 8.6 events/h), central apnea indices (CAI, 16.7 ± 5.4 versus 18.2 ± 7.1 events/h), oxygen desaturation indices (ODI,17.5 ± 13.1 versus 24.3 ± 11.9 events/h). During initial titration NPPV and servoventilation significantly improved the AHI (9.1 ± 4.3 versus 9 ± 6.4 events/h), AI (2 ± 3.1 versus 3.5 ± 4.5 events/h) CAI (2 ± 3.1 versus 2.5 ± 3.9 events/h) and ODI (10.1 ± 4.5 versus 8.9 ± 8.4 events/h) when compared to CPAP treatment (all P < 0.05). After 6 weeks we observed the following differences: AHI (16.5 ± 8 versus 7.4 ± 4.2 events/h, P = 0.027), AI (10.4 ± 5.9 versus 1.7 ± 1.9 events/h, P = 0.001), CAI (10.2 ± 5.1 versus 1.5 ± 1.7 events/h, P < 0.0001)) and ODI (21.1 ± 9.2 versus 4.8 ± 3.4 events/h, P < 0.0001) for NPPV and servoventilation, respectively. Other sleep parameters were unaffected by any form of treatment.
After 6 weeks, servoventilation treated respiratory events more effectively than NPPV in patients with complex sleep apnea syndrome.
比较无创正压通气(NPPV)和周期性反搏通气在持续气道正压通气(CPAP)诱导的中枢性睡眠呼吸暂停(复杂睡眠呼吸暂停)患者中的治疗效果。
随机对照试验。
睡眠中心。
30 名在 CPAP 治疗过程中发生复杂睡眠呼吸暂停综合征(CompSAS)的患者。
NPPV 或伺服通气。
患者被随机分配到 NPPV 或伺服通气组。6 周后进行全睡眠多导图(PSG)检查。在随机分组前 CPAP 治疗时,NPPV 和伺服通气组的呼吸暂停低通气指数(AHI,28.6±6.5 与 27.7±9.7 事件/小时(均值±标准差[SD]))、呼吸暂停指数(AI,19±5.6 与 21.1±8.6 事件/小时)、中枢性呼吸暂停指数(CAI,16.7±5.4 与 18.2±7.1 事件/小时)、氧减饱和度指数(ODI,17.5±13.1 与 24.3±11.9 事件/小时)相当。在初始滴定过程中,与 CPAP 治疗相比,NPPV 和伺服通气可显著改善 AHI(9.1±4.3 与 9±6.4 事件/小时)、AI(2±3.1 与 3.5±4.5 事件/小时)、CAI(2±3.1 与 2.5±3.9 事件/小时)和 ODI(10.1±4.5 与 8.9±8.4 事件/小时)(均 P<0.05)。6 周后我们观察到以下差异:AHI(16.5±8 与 7.4±4.2 事件/小时,P=0.027)、AI(10.4±5.9 与 1.7±1.9 事件/小时,P=0.001)、CAI(10.2±5.1 与 1.5±1.7 事件/小时,P<0.0001)和 ODI(21.1±9.2 与 4.8±3.4 事件/小时,P<0.0001),NPPV 和伺服通气组分别有差异。任何形式的治疗对其他睡眠参数均无影响。
6 周后,在复杂睡眠呼吸暂停综合征患者中,周期性反搏通气在治疗呼吸事件方面比 NPPV 更有效。